section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Local: burning, itching, local hypersensitivity reactions, redness, stinging

Interactions

Drug-drug:

Availability

Butenafine

(Generic available)

Ciclopirox

(Generic available)

Clotrimazole

(Generic available)

Econazole

(Generic available)

Efinaconazole

(Generic available)

Ketoconazole

(Generic available)

Luliconazole

(Generic available)

Miconazole

(Generic available)

Naftifine

Nystatin

(Generic available)

Oxiconazole

(Generic available)

Sertaconazole

Sulconazole

(Generic available)

Tavaborole

(Generic available)

Terbinafine

(Generic available)

Tolnaftate

(Generic available)

Route/Dosage

Butenafine

Ciclopirox

Clotrimazole

Econazole

Efinaconazole

Ketoconazole

Luliconazole

Miconazole

Naftifine

Nystatin

Oxiconazole

Sertaconazole

Sulconazole

Tavaborole

Terbinafine

Tolnaftate

US Brand Names

butenafine: Lotrimin Ultra,

ciclopirox: Ciclodan,

clotrimazole: Alevazol,

econazole: Ecoza,

efinaconazole: Jublia,

ketoconazole: Ketodan,

luliconazole: Luzu,

miconazole: Fungoid, Lotrimin AF, Micatin, Zeasorb-AF,

naftifine: Naftin,

nystatin: Klayesta, Mycostatin, Nyamyc, Nystop,

oxiconazole: Oxistat,

sertaconazole: Ertaczo,

sulconazole: Exelderm,

tavaborole: Kerydin,

terbinafine: Lamisil AT,

tolnaftate: Tinactin

Action

  • Butenafine, nystatin, clotrimazole, econazole, efinaconazole, ketoconazole, luliconazole, miconazole, naftifine, oxiconazole, sertaconazole, sulconazole, and terbinafine affect the synthesis of the fungal cell wall, allowing leakage of cellular contents. Tolnaftate distorts the hyphae and stunts mycelial growth in fungi. Ciclopirox inhibits the transport of essential elements in the fungal cell, disrupting the synthesis of DNA, RNA, and protein. Tavaborole inhibits fungal protein synthesis via inhibition of aminoacyl-transfer ribonucleic acid (tRNA) synthetase.
Therapeutic effects:
  • Decrease in symptoms of fungal infection.

Classifications

Therapeutic Classification: antifungals (topical)

Pharmacokinetics

Absorption: Absorption through intact skin is minimal.

Distribution: Distribution after topical administration is primarily local.

Metabolism/Excretion: Metabolism and excretion not known following local application.

Half-Life: Butenafine: 35 hr; Ciclopirox: 5.5 hr (gel); Efinaconazole: 29.9 hr; Terbinafine: 21 hr.

Canadian Brand Names

ciclopirox: Loprox,

clotrimazole: Canesten, Clotrimaderm,

ketoconazole: Ketoderm,

miconazole: Micozole,

nystatin: Nyaderm,

terbinafine: Lamisil

Time/Action Profile

( resolution of symptoms/lesions)
ROUTEONSETPEAKDURATION
Butenafineunknownup to 4 wkunknown
Luliconazoleunknown3–4 wkunknown
Tolnaftate24–72 hrunknownunknown

Only the drugs with known information included in this table.

Patient/Family Teaching

Pronunciation

butenafine: byoo-TEN-a-feen

ciclopirox: sye-kloe-PEER-ox

clotrimazole: kloe-TRYE-ma-zole

econazole: ee-KON-a-zole

efinaconazole: eff-in-a-KON-a-zole

ketoconazole: kee-toe-KOE-na-zole

luliconazole: loo-li-KON-a-zole

miconazole: mye-KON-a-zole

naftifine: NAFF-ti-feen

nystatin: nye-STAT-in

oxiconazole: ox-i-KON-a-zole

sertaconazole: ser-ta-KON-a-zole

sulconazole: sul-KON-a-zole

tavaborole: ta-va-BOR-ole

terbinafine: ter-BIN-a-feen

tolnaftate: tol-NAFF-tate